NCT03779282View on ClinicalTrials.gov

KETODEX for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

February 15, 2018

Primary Completion Date

September 15, 2018

Study Completion Date

September 15, 2018

Conditions
Emergence DeliriumStrabismus
Interventions
DRUG

Dexmedetomidine

see descriptions

Trial Locations (1)

70121

Ochsner Main Campus, Jefferson

Sponsors
All Listed Sponsors
lead

Ochsner Health System

OTHER

NCT03779282 - KETODEX for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery | Biotech Hunter | Biotech Hunter